Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Zhang, Xi  [Clear All Filters]
2019
Yan, C.-H., Liu, Q.-F., Wu, D.-P., Zhang, X., Xu, L.-P., Zhang, X.-H., Wang, Y., Huang, H., Bai, H., Huang, F., et al. (2019). Corrigendum to 'Prophylactic donor lymphocyte infusion (DLI) followed by minimal residual disease and graft-versus host disease guided multiple DLIs could improve outcomes after allogeneic hematopoietic stem cell transplantation in patients with refractor.Biol Blood Marrow Transplant.
Zhu, X.-F., He, H.-L., Wang, S.-Q., Tang, J.-Y., Han, B., Zhang, D.-H., Wu, L.-Q., Wu, D.-P., Li, W., Xia, L.-H., et al. (2019). Current Treatment Patterns of Aplastic Anemia in China: A Prospective Cohort Registry Study.Acta Haematol1-9.
Li, M., Chen, Y., Shi, J., Ju, W., Qi, K., Fu, C., Li, Z., Zhang, X., Qiao, J., Xu, K., et al. (2019). NLRP6 deficiency aggravates liver injury after allogeneic hematopoietic stem cell transplantation.Int Immunopharmacol74, 105740.
Zhang, C., Ma, Y.-Y., Liu, J., Liu, Y., Gao, L., Gao, L., Kong, P.-Y., Xiong, Q.-H., Mei, W.-L., Liu, J., et al. (2019). Preventive infusion of donor-derived CAR-T cells after haploidentical transplantation: Two cases report.Medicine (Baltimore)98, e16498.
Xuan, L., Wang, Y., Chen, J., Jiang, E., Gao, L., Wu, B., Deng, L., Liang, X., Huang, F., Fan, Z., et al. (2019). Sorafenib therapy is associated with improved outcomes for FLT3-ITD AML relapsing after allo-HSCT.Biol Blood Marrow Transplant.
Ma, Y., Zhang, Q., Kong, P., Xiong, J., Zhang, X., and Zhang, C. (2019). Treatment Selection for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors.Chemotherapy1-13.
Gao, L., Xiang, X., Zhang, C., Gao, L., Yang, T., Wang, S., Li, B., Lou, S., Lou, S., Liu, Y., et al. (2019). Upfront autologous hematopoietic stem cell transplantation in patients with high-risk stage III to IV Hodgkin lymphoma: a multicenter retrospective cohort study.Hematology24, 225-231.